SEC Form 4 · accession 0001662982-26-000002
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaodong Wang
Director · Other
Period of report
Sep 8, 2026
Accepted (ET)
Sep 10, 2026 · 4:49 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF4,F6 | Sep 8, 2026 | S | 1,181 | $345.383 | D | 6,079 | D | |
| American Depositary SharesF4,F7 | Sep 8, 2026 | S | 2,841 | $346.1575 | D | 3,238 | D | |
| American Depositary SharesF4,F8 | Sep 8, 2026 | S | 1,517 | $347.3915 | D | 1,721 | D | |
| American Depositary SharesF4,F9 | Sep 8, 2026 | S | 1,721 | $348.0126 | D | 0 | D | |
| American Depositary SharesF4 | Sep 8, 2026 | M | 31,027 | $36.90 | A | 31,027 | D | |
| American Depositary SharesF4,F10 | Sep 8, 2026 | S | 7,492 | $348.3146 | D | 23,535 | D | |
| American Depositary SharesF4,F11 | Sep 8, 2026 | S | 10,688 | $349.2834 | D | 12,847 | D | |
| American Depositary SharesF4,F12 | Sep 8, 2026 | S | 6,569 | $350.2741 | D | 6,278 | D | |
| American Depositary SharesF4,F13 | Sep 8, 2026 | S | 6,278 | $351.2542 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 4,588,113 | D | ||
| Ordinary SharesF1 | holding | — | — | — | 1,025,063 | I | See Footnote | |
| Ordinary SharesF2 | holding | — | — | — | 3,953,100 | I | See Footnote | |
| Ordinary SharesF3 | holding | — | — | — | 50 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F14,F15 | $2.84 | Sep 8, 2026 | M | 403,351 | D | — | Nov 15, 2026 | Ordinary Shares | 403,351 | 1,210,079 | D |
Explanation of responses
- F1These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
- F10The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.07 to $348.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F11The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.80 to $349.74, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F12The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.81 to $350.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F13The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.82 to $351.74, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F14The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- F15These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events.
- F2These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F3These securities are held by the spouse of the Reporting Person.
- F4Each American Depositary Share represents 13 Ordinary Shares.
- F5The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.71 to $345.66, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.71 to $346.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.79 to $347.78, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.80 to $348.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Remarks
Exhibit List - Exhibit 24.1 - Power of Attorney